Koers Omni Bio Pharmaceutical Inc OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
Omzet 2013 | - | Omzet 2014 | - | Marktkapitalisatie | 10,89 mln. 9,96 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | -7 mln. -6,4 mln. | Nettowinst (verlies) 2014 | -2 mln. -1,83 mln. | EV/omzet 2013 | - |
Nettoschuld 2013 | 441K 403K | Nettoschuld 2014 | 752K 688K | EV/omzet 2014 | - |
K/w-verhouding 2013 |
-1,5
x | K/w-verhouding 2014 |
-4,18
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,03% | 126 mld. | |
+23,61% | 118 mld. | |
+23,26% | 27,87 mld. | |
-18,07% | 20,95 mld. | |
-15,13% | 16,92 mld. | |
-14,81% | 16,18 mld. | |
+9,78% | 14,84 mld. | |
-46,10% | 14,79 mld. | |
+52,34% | 14,08 mld. |